Published in In Silico Biol on January 01, 2007
targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol (2008) 1.84
Comparative Pathway Analyzer--a web server for comparative analysis, clustering and visualization of metabolic networks in multiple organisms. Nucleic Acids Res (2008) 0.96
Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidates. PLoS One (2012) 0.95
Identification and modeling of a drug target for Clostridium perfringens SM101. Bioinformation (2010) 0.92
Vaccine Development Against Leishmania donovani. Front Immunol (2012) 0.90
A novel in silico approach to identify potential therapeutic targets in human bacterial pathogens. Hugo J (2011) 0.87
A systems biology approach to drug targets in Pseudomonas aeruginosa biofilm. PLoS One (2012) 0.85
Fresh Garlic Extract Enhances the Antimicrobial Activities of Antibiotics on Resistant Strains in Vitro. Jundishapur J Microbiol (2015) 0.81
Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis. BMC Genomics (2014) 0.81
A combined computational-experimental analyses of selected metabolic enzymes in Pseudomonas species. Int J Biol Sci (2008) 0.79
In silico quest for putative drug targets in Helicobacter pylori HPAG1: molecular modeling of candidate enzymes from lipopolysaccharide biosynthesis pathway. J Mol Model (2011) 0.78
Genome-wide Analysis of Mycoplasma hominis for the Identification of Putative Therapeutic Targets. Drug Target Insights (2014) 0.76
A Comparative Study of Metabolic Network Topology between a Pathogenic and a Non-Pathogenic Bacterium for Potential Drug Target Identification. Summit on Translat Bioinforma (2009) 0.76
An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach. Int J Mol Sci (2017) 0.75
Drug Target Identification and Prioritization for Treatment of Ovine Foot Rot: An In Silico Approach. Int J Genomics (2016) 0.75
In silico prediction of drug targets in Vibrio cholerae. Protoplasma (2010) 0.75
A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol (2004) 1.62
Comparative study of overlapping genes in bacteria, with special reference to Rickettsia prowazekii and Rickettsia conorii. Int J Syst Evol Microbiol (2005) 1.14
Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int J Biol Sci (2010) 1.10
Biodegradation of Low Density Polythene (LDPE) by Pseudomonas Species. Indian J Microbiol (2012) 1.09
An analysis on gene architecture in human and mouse genomes. In Silico Biol (2005) 0.97
In vitro combinations of antibiotics and phytochemicals against Pseudomonas aeruginosa. J Microbiol Immunol Infect (2009) 0.96
Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa. Int J Biol Sci (2009) 0.94
Pulse transit time as an indirect marker for variations in cardiovascular related reactivity. Technol Health Care (2006) 0.90
Quantitative analysis on the characteristics of targets with FDA approved drugs. Int J Biol Sci (2007) 0.90
Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network. J Drug Target (2010) 0.88
Targetability of human disease genes. Curr Drug Discov Technol (2007) 0.88
Infrared authentication of ginseng species: the use of the 2-6PC rule. J AOAC Int (2009) 0.84
Dual-channel photoplethysmography to monitor local changes in vascular stiffness. J Clin Monit Comput (2006) 0.83
Biocomputational strategies for microbial drug target identification. Methods Mol Med (2008) 0.82
Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology. J Drug Target (2012) 0.81
Evaluation of blood pressure changes using vascular transit time. Physiol Meas (2006) 0.81
Therapeutic implications of targeting energy metabolism in breast cancer. PPAR Res (2013) 0.80
Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus. Ann Clin Microbiol Antimicrob (2011) 0.80
In vitro drug interactions of gallates with antibiotics in Staphylococcus Aureus. Front Biosci (Elite Ed) (2010) 0.80
A combined computational-experimental analyses of selected metabolic enzymes in Pseudomonas species. Int J Biol Sci (2008) 0.79
Cloning and targeted disruption of two lipopolysaccharide biosynthesis genes, kdsA and waaG, of Pseudomonas aeruginosa PAO1 by site-directed mutagenesis. J Mol Microbiol Biotechnol (2010) 0.78
PPARγ disease gene network and identification of therapeutic targets for prostate cancer. J Drug Target (2011) 0.78
Bactericidal antibiotic-phytochemical combinations against methicillin resistant Staphylococcus aureus. Braz J Microbiol (2012) 0.78
Insights into antifolate activity of phytochemicals against Pseudomonas aeruginosa. J Drug Target (2010) 0.78
Authentication of traditional Chinese medicine using infrared spectroscopy: distinguishing between ginseng and its morphological fakes. J Biomed Sci (2006) 0.78
Development of a home screening system for pediatric respiratory sleep studies. Telemed J E Health (2006) 0.78
Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer. BMC Genomics (2013) 0.77
Intron position conservation across eukaryotic lineages in tubulin genes. Front Biosci (2005) 0.77
Gene fusion in Helicobacter pylori: making the ends meet. Antonie Van Leeuwenhoek (2006) 0.77
Comparative study for the effects of variable nutrient conditions on the biodegradation of microcystin-LR and concurrent dynamics in microcystin-degrading gene abundance. Bioresour Technol (2011) 0.77
Phonocardiographic signal analysis method using a modified hidden Markov model. Ann Biomed Eng (2006) 0.77
Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR. Drug Des Devel Ther (2013) 0.77
A Comparative Study of Metabolic Network Topology between a Pathogenic and a Non-Pathogenic Bacterium for Potential Drug Target Identification. Summit on Translat Bioinforma (2009) 0.76
Biofluid mechanics of the human reproductive process: modelling of the complex interaction and pathway to the oocytes. Zygote (2008) 0.76
Hybrid-drug design targeting Pseudomonas aeruginosa DHPS and DHFR. Front Biosci (Elite Ed) (2013) 0.76
Human genomic diversity, viral genomics and proteomics, as exemplified by human papillomaviruses and H5N1 influenza viruses. Hum Genomics (2009) 0.75
Mammalian specific mouse genes are evolving faster than mouse genes conserved across other eukaryotic lineages. Front Biosci (2007) 0.75
Changes induced in the lower- and upper-limb pulse transit-time ratio during inspiratory resistive breathing. Biomed Tech (Berl) (2007) 0.75
Study of pulse transit time oscillations during obstructive sleep apnoea by using a distributed model. J Biomech (2007) 0.75
Pulse transit time based on piezoelectric technique at the radial artery. J Clin Monit Comput (2006) 0.75
Human genome -- from pieces to patterns. Front Biosci (2005) 0.75